Community post

James Doub (University of Maryland School of Medicine) and colleagues published a new paper in Pharmaceuticals on their successful treatment of a recalcitrant Staphylococcus epidermidis prosthetic knee infection with intraoperative phage therapy. The phage used in this case is the first ɛ2 phage ('bred' phages generated at PhagoMed by superinfecting S. epidermidis strains with multiple wild type phages) to be used in vivo.